JP2010047612A5 - - Google Patents

Download PDF

Info

Publication number
JP2010047612A5
JP2010047612A5 JP2009272270A JP2009272270A JP2010047612A5 JP 2010047612 A5 JP2010047612 A5 JP 2010047612A5 JP 2009272270 A JP2009272270 A JP 2009272270A JP 2009272270 A JP2009272270 A JP 2009272270A JP 2010047612 A5 JP2010047612 A5 JP 2010047612A5
Authority
JP
Japan
Prior art keywords
nateglinide
preparation according
tablet
preparation
per tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009272270A
Other languages
English (en)
Japanese (ja)
Other versions
JP5282722B2 (ja
JP2010047612A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2009272270A priority Critical patent/JP5282722B2/ja
Priority claimed from JP2009272270A external-priority patent/JP5282722B2/ja
Publication of JP2010047612A publication Critical patent/JP2010047612A/ja
Publication of JP2010047612A5 publication Critical patent/JP2010047612A5/ja
Application granted granted Critical
Publication of JP5282722B2 publication Critical patent/JP5282722B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2009272270A 2003-08-08 2009-11-30 ナテグリニド含有製剤 Expired - Fee Related JP5282722B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009272270A JP5282722B2 (ja) 2003-08-08 2009-11-30 ナテグリニド含有製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003290464 2003-08-08
JP2003290464 2003-08-08
JP2009272270A JP5282722B2 (ja) 2003-08-08 2009-11-30 ナテグリニド含有製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005513036A Division JP4505859B2 (ja) 2003-08-08 2004-08-09 ナテグリニド含有製剤

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2011222076A Division JP4947820B2 (ja) 2003-08-08 2011-10-06 ナテグリニド含有製剤
JP2012236421A Division JP5557169B2 (ja) 2003-08-08 2012-10-26 ナテグリニド含有製剤

Publications (3)

Publication Number Publication Date
JP2010047612A JP2010047612A (ja) 2010-03-04
JP2010047612A5 true JP2010047612A5 (OSRAM) 2012-01-05
JP5282722B2 JP5282722B2 (ja) 2013-09-04

Family

ID=34131587

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2005513036A Expired - Lifetime JP4505859B2 (ja) 2003-08-08 2004-08-09 ナテグリニド含有製剤
JP2008265459A Expired - Fee Related JP4995798B2 (ja) 2003-08-08 2008-10-14 ナテグリニド含有製剤
JP2009272270A Expired - Fee Related JP5282722B2 (ja) 2003-08-08 2009-11-30 ナテグリニド含有製剤
JP2011222076A Expired - Lifetime JP4947820B2 (ja) 2003-08-08 2011-10-06 ナテグリニド含有製剤
JP2012236421A Expired - Lifetime JP5557169B2 (ja) 2003-08-08 2012-10-26 ナテグリニド含有製剤

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2005513036A Expired - Lifetime JP4505859B2 (ja) 2003-08-08 2004-08-09 ナテグリニド含有製剤
JP2008265459A Expired - Fee Related JP4995798B2 (ja) 2003-08-08 2008-10-14 ナテグリニド含有製剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2011222076A Expired - Lifetime JP4947820B2 (ja) 2003-08-08 2011-10-06 ナテグリニド含有製剤
JP2012236421A Expired - Lifetime JP5557169B2 (ja) 2003-08-08 2012-10-26 ナテグリニド含有製剤

Country Status (4)

Country Link
US (1) US7732492B2 (OSRAM)
JP (5) JP4505859B2 (OSRAM)
KR (2) KR20080083071A (OSRAM)
WO (1) WO2005013964A1 (OSRAM)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3227424B2 (ja) 1998-02-13 2001-11-12 大日精化工業株式会社 育成効果を有する芝生着色剤組成物
CA2426263C (en) * 2000-10-24 2010-05-25 Ajinomoto Co., Inc. Nateglinide-containing preparation
JP4505859B2 (ja) * 2003-08-08 2010-07-21 味の素株式会社 ナテグリニド含有製剤
KR101082774B1 (ko) * 2006-04-12 2011-11-11 닛뽕소다 가부시키가이샤 서방성 정제의 제조 방법
US10741034B2 (en) 2006-05-19 2020-08-11 Apdn (B.V.I.) Inc. Security system and method of marking an inventory item and/or person in the vicinity
US9790538B2 (en) 2013-03-07 2017-10-17 Apdn (B.V.I.) Inc. Alkaline activation for immobilization of DNA taggants
TWI482641B (zh) 2006-12-07 2015-05-01 Daiichi Sankyo Co Ltd 含有低取代度羥丙基纖維素之醫藥組成物
KR101442862B1 (ko) * 2006-12-07 2014-09-22 다이이찌 산쿄 가부시키가이샤 만니톨 또는 유당을 함유하는 고형 제제
WO2008072533A1 (ja) * 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 固形製剤の製造方法
EP2100606A4 (en) * 2006-12-07 2009-12-30 Daiichi Sankyo Co Ltd PREPARATION WITH FILM COVER AND IMPROVED STABILITY
WO2008136393A1 (ja) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. ラクタム化合物の結晶形およびその製造方法
TR200801178A2 (tr) * 2008-02-22 2009-09-23 Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. Nateglinid ve surfaktan-ph ayarlayıcı sistemi içeren oral tablet kompozisyonları
NZ595071A (en) * 2009-03-13 2013-01-25 Toyama Chemical Co Ltd Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
GB201003766D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
CN106963741A (zh) * 2010-03-29 2017-07-21 Ea制药株式会社 含有苯基丙氨酸衍生物的医药制剂
WO2013066278A1 (en) * 2011-11-03 2013-05-10 Mahmut Bilgic A process for production of pharmaceutical formulations comprising nateglinide
WO2013115739A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic Production method for formulations comprising comprising nateglinide and lipoic acid
KR101707938B1 (ko) 2012-03-29 2017-02-17 주식회사 다이셀 산형(酸型) 카르복시 메틸 셀룰로오스를 포함하는 붕해성 입자 조성물의 제조 방법, 및 상기 조성물과 상기 조성물을 포함하는 구강내 붕해 정제
US9297032B2 (en) * 2012-10-10 2016-03-29 Apdn (B.V.I.) Inc. Use of perturbants to facilitate incorporation and recovery of taggants from polymerized coatings
US9266370B2 (en) 2012-10-10 2016-02-23 Apdn (B.V.I) Inc. DNA marking of previously undistinguished items for traceability
US9963740B2 (en) 2013-03-07 2018-05-08 APDN (B.V.I.), Inc. Method and device for marking articles
WO2015046219A1 (ja) * 2013-09-27 2015-04-02 株式会社ダイセル 崩壊性粒子組成物を含む口腔内崩壊錠剤
CA2926436A1 (en) 2013-10-07 2015-04-16 Judith Murrah Multimode image and spectral reader
US10745825B2 (en) 2014-03-18 2020-08-18 Apdn (B.V.I.) Inc. Encrypted optical markers for security applications
JP2017512692A (ja) 2014-03-18 2017-05-25 エーピーディーエヌ（ビー・ヴイ・アイ）・インコーポレイテッド セキュリティ用途のための暗号化された光学マーカー
US10760182B2 (en) 2014-12-16 2020-09-01 Apdn (B.V.I.) Inc. Method and device for marking fibrous materials
CN109070130B (zh) 2016-04-11 2022-03-22 亚普蒂恩（B V I）公司 用于标记纤维素产品的方法
US10995371B2 (en) 2016-10-13 2021-05-04 Apdn (B.V.I.) Inc. Composition and method of DNA marking elastomeric material
WO2018156352A1 (en) 2017-02-21 2018-08-30 Apdn (B.V.I) Inc. Nucleic acid coated submicron particles for authentication

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
JPS5438167B2 (OSRAM) * 1974-04-27 1979-11-19
JPS5344618A (en) * 1976-10-04 1978-04-21 Takeda Chem Ind Ltd Preparation of tablet
ATE13486T1 (de) * 1980-11-12 1985-06-15 Ciba Geigy Ag Schnellzerfallende arzneimittel-presslinge.
WO1987005804A1 (en) * 1986-04-01 1987-10-08 The Upjohn Company Methylprednisolone/sodium carboxymethyl starch tablet composition
JPH0415221A (ja) 1990-05-08 1992-01-20 Daicel Chem Ind Ltd ポリカーボネートの製造法
JPH09208468A (ja) * 1996-02-02 1997-08-12 Dainippon Pharmaceut Co Ltd ｐ−クロロ−Ｎ−（２−モルホリノエチル）ベンズアミドを含有する錠剤
PT1166651E (pt) * 1996-02-29 2005-04-29 Fujisawa Pharmaceutical Co Granulos de desintegracao rapida de um edulcorante sintetico contendo acido silicico e/ou dioxido de silicio
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
KR100395607B1 (ko) * 1996-07-01 2004-01-31 화이자 인코포레이티드 버지니아마이신혼합물
DE69740161D1 (de) * 1996-11-15 2011-05-12 Ajinomoto Kk Nateglinide-Tablettenzubereitungen
JPH10298062A (ja) * 1997-04-24 1998-11-10 Pfizer Pharmaceut Co Ltd 口腔内速溶型錠剤
JP2945001B1 (ja) * 1997-09-10 1999-09-06 大日本製薬株式会社 カーボン１３尿素含有錠
US20060182802A1 (en) * 1998-07-28 2006-08-17 Toshihiro Shimizu Rapidly disintegrable solid preparation
JP2000178184A (ja) * 1998-12-17 2000-06-27 Lion Corp 粒状組成物、錠剤及び粒状組成物の製造方法
JP2000351732A (ja) * 1999-06-07 2000-12-19 Taisho Pharm Ind Ltd 水分散性良好なアシクロビル含有錠剤
BR0012863A (pt) * 1999-08-03 2002-04-16 Lilly Icos Llc Composições farmacêuticas de "beta"-carbolina
US6559188B1 (en) * 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
CO5200844A1 (es) * 1999-09-17 2002-09-27 Novartis Ag Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes
RU2264811C2 (ru) 1999-12-23 2005-11-27 Новартис Аг Применение гипогликемического агента для лечения нарушенного метаболизма глюкозы
EP1616561B1 (en) * 1999-12-28 2008-06-25 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
AR028253A1 (es) * 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa
AU8576801A (en) 2000-06-22 2002-01-02 Novartis Ag Pharmaceutical compositions
JP2002087960A (ja) * 2000-07-14 2002-03-27 Toyama Chem Co Ltd 徐放性錠剤
US20040034039A1 (en) 2000-09-22 2004-02-19 Yoshinori Nakano Solid preparations
JPWO2002040010A1 (ja) * 2000-10-24 2004-06-03 味の素株式会社 ナテグリニド含有親水性医薬製剤
CA2426263C (en) * 2000-10-24 2010-05-25 Ajinomoto Co., Inc. Nateglinide-containing preparation
JP4370050B2 (ja) * 2000-12-04 2009-11-25 大正製薬株式会社 クラリスロマイシン錠剤およびその製造法
JP2002326925A (ja) * 2001-04-27 2002-11-15 Asahi Breweries Ltd 造粒物および錠剤の製造方法
GB0128378D0 (en) 2001-11-27 2002-01-16 Smithkline Beecham Plc Novel Compounds
JP2003201256A (ja) 2001-12-28 2003-07-18 Hisamitsu Pharmaceut Co Inc 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
JP4029926B2 (ja) * 2002-01-25 2008-01-09 サンウエーブ工業株式会社 回転式載置台
US6830759B2 (en) * 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
JP4505859B2 (ja) * 2003-08-08 2010-07-21 味の素株式会社 ナテグリニド含有製剤
CN1557291A (zh) 2004-01-14 2004-12-29 杨喜鸿 那格列奈分散片及其制备方法
WO2005094812A1 (ja) 2004-04-01 2005-10-13 Ajinomoto Co., Inc. ナテグリニド含有製剤
JP2008265459A (ja) 2007-04-18 2008-11-06 Daihatsu Motor Co Ltd アクスルハウジング

Similar Documents

Publication Publication Date Title
JP2010047612A5 (OSRAM)
JP2011037832A5 (OSRAM)
NO20084992L (no) Farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel
HRP20211752T1 (hr) Farmaceutski pripravci 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline i njihova primjena
UA116334C2 (uk) Тверді форми дозування бендамустину
NO20083151L (no) Fast dispersjon omfattende en aktiv bestanddel med et lavt smeltepunkt, og tablett for oral administrering omfattende samme
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
JP2009537554A5 (OSRAM)
JP2010520246A5 (OSRAM)
MX2009011554A (es) Preparacion solida estable conteniendo un derivado de 4,5-epoximorfinano.
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
JP2011506587A5 (OSRAM)
JP2014221827A5 (OSRAM)
AR061790A1 (es) Composicion farmaceutica solida para la administracion oral, formulaciones de comprimidos de liberacion inmediata de un antagonista del receptor de trombina, y su uso en la manufactura de un medicamento
RU2014137096A (ru) Перорально вводимая фармацевтическая композиция
RU2007107368A (ru) Композиция, содержащая десмопрессин
UA101407C2 (ru) Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат
PL1994926T3 (pl) Preparaty walsartanu
JP2018039810A5 (OSRAM)
MY153109A (en) A solid pharmaceutical formulation
JP2014218523A5 (OSRAM)
NO20090262L (no) Galeniske formuleringer av aliskiren og hydroklorotiazid
JP2015129124A5 (OSRAM)
JP2006342148A5 (OSRAM)
JP2013528213A5 (OSRAM)